类风湿关节炎标准化死亡比的吸烟相关偏倚:一项建模研究
该建模研究利用1999-2004年美国国家健康访谈调查数据,构建具有类风湿关节炎(RA)典型年龄性别构成的假想队列,以一般人群当前吸烟率21.8%为参照,模拟RA中较高的吸烟率,并设定吸烟相对危险度为1.25、1.5、1.75和2.0,在2000次重复样本中计算10年和15年标准化死亡比(SMR)。结果显示,即使吸烟率轻度增加(相对危险度1.25),10年SMR中位数为1.07、15年为1.04;相对危险度2.0时,10年SMR中位数为1.23、15年为1.17。结论认为RA的SMR可能因吸烟率高于一般人群而被高估,此时以1.0作为等死亡结局的基准过严。
要点
- RA中吸烟率高于一般人群可致SMR偏倚,即使吸烟相对危险度仅1.25,10年SMR中位数亦达1.07。
- 吸烟相对危险度2.0时,假想RA队列10年SMR中位数为1.23、15年为1.17。
- 以SMR=1.0作为RA与一般人群死亡结局相等的基准可能过严。
核心结论
- RA的SMR可能因吸烟率相对一般人群的轻度增加而被高估,此时以1.0作为等死亡结局的SMR基准过严。
研究设计与样本
- 建模研究,使用1999-2004年美国国家健康访谈调查数据构建假想队列,年龄30至79岁、70%为女性,参照队列当前吸烟率为21.8%。
- 另建吸烟比例更高的队列,吸烟相对危险度分别为1.25、1.5、1.75和2.0,在2000次重复样本中计算10年和15年SMR。
主要发现
- 参照队列当前吸烟率为21.8%。
- 吸烟相对危险度2.0的假想RA队列,10年SMR中位数为1.23,15年为1.17。
- 吸烟相对危险度1.25的假想RA队列,10年SMR中位数为1.07,15年为1.04。
- 基于曾经吸烟者与从不吸烟者比较的相对危险度计算的SMR,结果相似。
- 假想RA组与参照队列间吸烟强度的差异对SMR影响较小。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Standardized mortality ratios (SMRs) for rheumatoid arthritis (RA) are age- and sex-matched to the general population, but may be biased because smoking is more common in the RA group. This modeling study used national mortality data on smokers and non-smokers to estimate the effect on SMRs of the higher smoking prevalences typically found in RA. METHODS: Data from the United States National Health Interview Surveys 1999-2004 were used to create hypothetical cohorts with an age-sex composition typical of patients with RA (age 30 to 79; 70 % women). The reference cohort had the smoking prevalence of the general population (21.8 % current smokers). Additional cohorts were created that had higher proportions of smokers, approximating the prevalence of smoking commonly present in RA, with smoking relative risks of 1.25, 1.5, 1.75, and 2.0 compared to the reference cohort. SMRs were computed on 2000 replicate samples in which mortality over 10 years and 15 years was compared between the higher-smoking simulated RA cohorts and the reference cohort. RESULTS: The reference cohort had a prevalence of current smoking of 21.8 %. In a hypothetical RA cohort with a higher smoking prevalence, equal to a smoking relative risk of 2.0 compared to the general population, the median SMR for RA was 1.23 at 10 years and 1.17 at 15 years. At a smoking prevalence equivalent to a relative risk of 1.25, the median SMR for RA was 1.07 at 10 years and 1.04 at 15 years. Results were similar for SMRs based on relative risks that compared ever smokers to never smokers. Differences in smoking intensity between the hypothetical RA groups and reference cohorts had small effects on SMRs. CONCLUSIONS: SMRs in RA may be inflated by even small increases in the prevalence of smoking relative to the general population. In these cases, an SMR benchmark of 1.0 to represent equal mortality outcomes would be too strict.
引用
- Ward MM. Smoking-related bias of standardized mortality ratios in rheumatoid arthritis: A modeling study. Semin Arthritis Rheum. 2024. PMID: 39591755. doi:10.1016/j.semarthrit.2024.152599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。